235 related articles for article (PubMed ID: 27372421)
1. In situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery.
Deepagan VG; Kwon S; You DG; Nguyen VQ; Um W; Ko H; Lee H; Jo DG; Kang YM; Park JH
Biomaterials; 2016 Oct; 103():56-66. PubMed ID: 27372421
[TBL] [Abstract][Full Text] [Related]
2. Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo.
Dai L; Yu Y; Luo Z; Li M; Chen W; Shen X; Chen F; Sun Q; Zhang Q; Gu H; Cai K
Biomaterials; 2016 Oct; 104():1-17. PubMed ID: 27423095
[TBL] [Abstract][Full Text] [Related]
3. Effect of hydrophobicity of core on the anticancer efficiency of micelles as drug delivery carriers.
Sun CY; Ma YC; Cao ZY; Li DD; Fan F; Wang JX; Tao W; Yang XZ
ACS Appl Mater Interfaces; 2014 Dec; 6(24):22709-18. PubMed ID: 25426800
[TBL] [Abstract][Full Text] [Related]
4. Interface crosslinked mPEG-b-PAGE-b-PCL triblock copolymer micelles with high stability for anticancer drug delivery.
Lu Y; Gao X; Cao M; Wu B; Su L; Chen P; Miao J; Wang S; Xia R; Qian J
Colloids Surf B Biointerfaces; 2020 May; 189():110830. PubMed ID: 32045844
[TBL] [Abstract][Full Text] [Related]
5. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
[TBL] [Abstract][Full Text] [Related]
6. Visible light-induced crosslinking and physiological stabilization of diselenide-rich nanoparticles for redox-responsive drug release and combination chemotherapy.
Zhai S; Hu X; Hu Y; Wu B; Xing D
Biomaterials; 2017 Mar; 121():41-54. PubMed ID: 28068593
[TBL] [Abstract][Full Text] [Related]
7. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
[TBL] [Abstract][Full Text] [Related]
8. Facile construction of dual-bioresponsive biodegradable micelles with superior extracellular stability and activated intracellular drug release.
Chen W; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
J Control Release; 2015 Jul; 210():125-33. PubMed ID: 25987525
[TBL] [Abstract][Full Text] [Related]
9. Self-Assembled Monomethoxy (Polyethylene Glycol)-b-P(D,L-Lactic-co-Glycolic Acid)-b-P(L-Glutamic Acid) Hybrid-Core Nanoparticles for Intracellular pH-Triggered Release of Doxorubicin.
Xu H; Cai C; Gou J; Sui B; Jin J; Xu H; Zhang Y; Wang L; Zhai Y; Tang X
J Biomed Nanotechnol; 2015 Aug; 11(8):1354-69. PubMed ID: 26295138
[TBL] [Abstract][Full Text] [Related]
10. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE
Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684
[TBL] [Abstract][Full Text] [Related]
11. Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions.
Wu L; Zou Y; Deng C; Cheng R; Meng F; Zhong Z
Biomaterials; 2013 Jul; 34(21):5262-72. PubMed ID: 23570719
[TBL] [Abstract][Full Text] [Related]
12. Mesoscopic simulations of drug-loaded diselenide crosslinked micelles: Stability, drug loading and release properties.
Lin W; Xue Z; Wen L; Li Y; Liang Z; Xu J; Yang C; Gu Y; Zhang J; Zu X; Luo H; Yi G; Zhang L
Colloids Surf B Biointerfaces; 2019 Oct; 182():110313. PubMed ID: 31306830
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer.
Ye WL; Zhao YP; Li HQ; Na R; Li F; Mei QB; Zhao MG; Zhou SY
Sci Rep; 2015 Sep; 5():14614. PubMed ID: 26419507
[TBL] [Abstract][Full Text] [Related]
14. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
[TBL] [Abstract][Full Text] [Related]
15. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
16. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy.
Hu FQ; Zhang YY; You J; Yuan H; Du YZ
Mol Pharm; 2012 Sep; 9(9):2469-78. PubMed ID: 22827551
[TBL] [Abstract][Full Text] [Related]
17. Reduction/temperature/pH multi-stimuli responsive core cross-linked polypeptide hybrid micelles for triggered and intracellular drug release.
Qu J; Wang QY; Chen KL; Luo JB; Zhou QH; Lin J
Colloids Surf B Biointerfaces; 2018 Oct; 170():373-381. PubMed ID: 29940504
[TBL] [Abstract][Full Text] [Related]
18. pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics.
Lin W; Yao N; Qian L; Zhang X; Chen Q; Wang J; Zhang L
Acta Biomater; 2017 Aug; 58():455-465. PubMed ID: 28583900
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of redox-responsive Bi(mPEG-PLGA)-Se
Birhan YS; Hailemeskel BZ; Mekonnen TW; Hanurry EY; Darge HF; Andrgie AT; Chou HY; Lai JY; Hsiue GH; Tsai HC
Int J Pharm; 2019 Aug; 567():118486. PubMed ID: 31260783
[TBL] [Abstract][Full Text] [Related]
20. Bioreducible Micelles with Endosomal Buffering and Multidrug Resistance-Reversing Function Enhance Anti-Tumor Efficacy of Doxorubicin.
Yin Q; Shen J; Yu H; Huang Y; Zhang Z; Li Y
J Biomed Nanotechnol; 2015 Oct; 11(10):1764-75. PubMed ID: 26502639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
